Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: A meta-analysis

Journal of the Medical Association of Thailand

Volumn 92, Issue 5, 2009, Pages 632-637

  Pongprasobchai, Supot ^a   Kridkratoke, Samruay ^a   Nopmaneejumruslers, Cherdchai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Histamine 2 receptor antagonist; Omeprazole; Prophylaxis; Proton pump inhibitor; Stress ulcer; Stress related mucosal disease

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CRITICALLY ILL PATIENT; GASTROINTESTINAL HEMORRHAGE; HOSPITAL INFECTION; HUMAN; META ANALYSIS; MORBIDITY; MUCOSAL DISEASE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; THERAPY EFFECT;

ANTI-ULCER AGENTS; CONFIDENCE INTERVALS; CRITICAL ILLNESS; CROSS INFECTION; GASTRIC MUCOSA; HISTAMINE H2 ANTAGONISTS; HUMANS; ODDS RATIO; PEPTIC ULCER; PNEUMONIA; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOMACH DISEASES; STRESS, PHYSIOLOGICAL; TREATMENT OUTCOME;

EID: 66649092882     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care 2005; 20: 35-45.
2. Cook DJ, Griffith LE, Walter SD, Guyatt GH, Meade MO, Heyland DK, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001; 5: 368-75.
3. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994; 330: 377-81.
4. Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffith LE, Buckingham L, et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 1996; 275: 308-14.
5. Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 1998; 338: 791-7.
6. Brett S. Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness. Crit Care 2005; 9: 45-50.
7. Lasky MR, Metzler MH, Phillips JO. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma 1998; 44: 527-33.
8. Phillips JO, Metzler MH, Palmieri MT, Huckfeldt RE, Dahl NG. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med 1996; 24: 1793-800.
9. Levy MJ, Seelig CB, Robinson NJ, Ranney JE. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 1997; 42: 1255-9.